Skip to main navigation Skip to search Skip to main content

The test-retest reliability of non-navigated transcranial magnetic stimulation (TMS) measures of corticospinal pathway excitability early after stroke

Research output: Contribution to journalArticlepeer-review

63 Downloads (Pure)

Abstract

Purpose: Motor evoked potential (MEP) characteristics are potential biomarkers of whether rehabilitation interventions drive motor recovery after stroke. The test-retest reliability of Transcranial Magnetic Stimulation (TMS) measurements in sub-acute stroke remains unclear. This study aims to determine the test-retest reliability of upper limb MEP measures elicited by non-neuronavigated transcranial magnetic stimulation in sub-acute-stroke. Methods: In two identical data collection sessions, 1–3 days apart, TMS measures assessed: motor threshold (MT), amplitude, latency (MEP-L), silent period (SP), recruitment curve slope in the biceps brachii (BB), extensor carpi radialis (ECR), and abductor pollicis brevis (APB) muscles of paretic and non-paretic upper limbs. Test-retest reliability was calculated using the intra-class correlation coefficient (ICC) and 95% confidence intervals (CI). Acceptable reliability was set at a lower 95% CI of 0.70 or above. The limits of agreement (LOA) and smallest detectable change (SDC) were calculated. Results: 30 participants with sub-acute stroke were included (av 36 days post stroke) reliability was variable between poor to good for the different MEP characteristics. The SDC values differed across muscles and MEP characteristics in both paretic and less paretic limbs. Conclusions: The present findings indicate there is limited evidence for acceptable test-retest reliability of non-navigated TMS outcomes when using the appropriate 95% CI for ICC, SDC and LOA values. Clinical Trial Registration: Current Controlled Trials: ISCRT 19090862, http://www.controlled-trials.com.

Original languageEnglish
Pages (from-to)6439-6446
Number of pages8
JournalDisability and Rehabilitation
Volume46
Issue number26
Early online date18 Apr 2024
DOIs
Publication statusPublished online - 18 Apr 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Funding

Professor Pomeroy is grateful for the support of the National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Acknowledgements

Funders
University of Cambridge

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • transcranial magnetic stimulation (TMS)
    • Test-retest reliability
    • upper limb
    • stroke
    • smallest detectable change
    • Reproducibility of Results
    • Stroke Rehabilitation/methods
    • Humans
    • Middle Aged
    • Stroke/physiopathology
    • Recovery of Function/physiology
    • Male
    • Evoked Potentials, Motor/physiology
    • Transcranial Magnetic Stimulation
    • Pyramidal Tracts/physiopathology
    • Female
    • Adult
    • Aged
    • Electromyography
    • Muscle, Skeletal/physiopathology
    • Upper Extremity/physiopathology
    • Paresis/physiopathology

    Fingerprint

    Dive into the research topics of 'The test-retest reliability of non-navigated transcranial magnetic stimulation (TMS) measures of corticospinal pathway excitability early after stroke'. Together they form a unique fingerprint.

    Cite this